Role of Echocardiography in Aortic Stenosis Natesa G. Pandian, Alamelu Ramamurthi, Sarah Applebaum PII: DOI: Reference:
S0033-0620(14)00070-X doi: 10.1016/j.pcad.2014.05.006 YPCAD 594
To appear in:
Progress in Cardiovascular Diseases
Please cite this article as: Pandian Natesa G., Ramamurthi Alamelu, Applebaum Sarah, Role of Echocardiography in Aortic Stenosis, Progress in Cardiovascular Diseases (2014), doi: 10.1016/j.pcad.2014.05.006
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT 1
RI P
Natesa G. Pandian, MD, FACC
T
Role of Echocardiography in Aortic Stenosis
Alamelu Ramamurthi, MD
MA
NU
SC
Sarah Applebaum, MS
From
ED
Tufts Medical Center Tufts University School of Medicine
AC
CE
PT
Boston, MA
Correspondance: Natesa G. Pandian, MD, FACC Tufts Medical Center 800 Washington Street, Boston, MA 02111
Email:
[email protected] Phone: 617 875 5755 FAX: 617 636 8070
ACCEPTED MANUSCRIPT 2
Abstract
T
Aortic stenosis is a valve disorder that includes not only valve narrowing but also changes in the
RI P
left ventricle and intracardiac hemodynamics. Older patients with aortic stenosis often have co-
SC
existing pathologic disorders, which influence the pathophysiology, symptom expression and prognosis. There is also increasing awareness that severe aortic stenosis could be associated
NU
with low transvalvular pressure gradient caused by a variety of mechanisms. Surgical and
MA
transcutaneous valve replacements are currently available interventions for patients with severe aortic stenosis. This article reviews the role of echocardiography in the comprehensive
Keywords:
AC
Echocardiography
CE
PT
ED
assessment of aortic stenosis, its severity and associated pathophysiologic abnormalities.
Aortic stenosis
Aortic valve disease Low gradient aortic stenosis Valve disease
ACCEPTED MANUSCRIPT 3
T
Role of Echocardiography in Aortic Stenosis
RI P
During the last decade, new insights on the clinical features, presentation, and prognosis of
SC
patients with aortic stenosis (AS), and the emerging option of transcutaneous aortic valve implantation (TAVI) in selected patients have placed emphasis on the need to approach aortic
NU
stenosis not just in terms of valve stenosis and gradients, but much more comprehensively. The
MA
etiology of AS include congenital lesions, commonly a bicuspid aortic valve, degenerative calcification of the valve cusps, rheumatic fever-related commissural fusion, and rare systemic
ED
or therapy-induced mechanisms. Severe AS, if uncompensated and uncorrected, leads to disabling symptoms and decreased survival.1,2 For optimal clinical decision making,
PT
comprehensive diagnostic evaluation of patients with aortic valve disease requires assessment
CE
of the morphology of the valve, severity of the valve lesion, size of the aorta, systemic arterial afterload, impact on LV size and function, consequences of abnormal LV function and
AC
hemodynamics on pulmonary artery pressures, right ventricular size and function, and coexistent disorders. Echocardiography, with its two- and three-dimensional imaging capabilities, and various Doppler modalities, allows for examination of the valve pathology, as well as hemodynamics, and has therefore become the diagnostic method of choice, and the guide for optimal management of patients with AS. Echocardiographic data should be integrated with the clinical features of a patient, other imaging, and, when needed, catheterization findings in order to approach AS in a syndromatic fashion. This article will review the role of echocardiography in patients with AS.
ACCEPTED MANUSCRIPT 4
Assessment of the severity of aortic stenosis
T
Normal aortic valve area (AVA) is considered to range from 2 to 4.5 cm2. This observation is
RI P
based on a few reports from a small series of subjects. As AVA progressively decreases, it
SC
results in an increasing pressure gradient between the LV and aorta, and an increasing flow velocity across the valve. In the past, the severity of AS was determined by invasively
NU
measuring cardiac output and pressure gradients across the valve, and employing Gorlin
MA
equation, or other similar equations, to derive the AVA. Such methods of obtaining AVA, however, were poorly validated and their accuracy never appropriately tested in the setting of
ED
abnormal flow states, increased afterload, or co-existent disorders.
PT
Aortic Valve Pathology
CE
Two-dimensional and three-dimensional imaging portrays the pathology of a stenotic aortic valve. The number of valve cusps, valve thickening, commissural fusion, calcific burden on the
AC
valve, and restricted motion are visualized in the long-axis and short-axis imaging planes. 3-5 (Figure 1). In most adult patients with AS, the valve has three thickened and calcified cusps. Valve thickening and calcification may involve all cusps or only part of the valve. A bicuspid valve has two cusps with complete or partial fusion in the conjoint cusp, and an oval appearance. The raphe is generally directed towards the pulmonic valve or tricuspid valve direction. If stenosis is not severe, the valve exhibits systolic bowing in the long-axis view that gives a clue to the bicuspid nature of the valve.
ACCEPTED MANUSCRIPT 5
Aortic valve area can be measured by planimetry, except in the presence of a markedly calcified
T
or deformed valve. 6-8 Three-dimensional imaging is helpful in correctly representing the valve
RI P
in an optimal orientation. 5 In addition to the valve area, other measurements of importance include diameters of the aortic ring and aortic root at the level of the sinus of Valsalva, sino-
SC
tubular junction, and proximal ascending aorta. If surgical replacement or transcatheter
NU
implantation is considered, these parameters have implications on the choice of the valve prosthesis. In patients with bicuspid aortic valve, which is often associated with a
MA
morphologically weak aortic wall that may dilate into an aneurysm and risk rupture, the
ED
dimensions of the aortic root and ascending aorta should be noted and monitored.
PT
Severity of Aortic Stenosis
Patients with severe AS can be categorized as mild (AVA > 1.5), moderate (AVA 1.0-1.5), or
Severe AS can be further divided into those with normal flow and high gradient (mean
AC
10,10A
CE
severe (AVA ≤ 1.0 or AVAi ≤ 0.6 cm2/m2) based on AVA and various other empirical criteria. 9-
gradient above 40 mm Hg), and those with low flow and low gradient (mean gradient 40 mm Hg or less). Reflection on the mechanism of low gradient is needed in gauging the prognosis and deciding on appropriate therapy. Flow Velocity and Pressure Gradients in Aortic Stenosis As determined by the Doppler echocardiographic approach, the severity of aortic stenosis is discerned by deriving flow velocity, stroke volume, pressure gradient, and quantitation of aortic valve area (Figure 2). A maximum aortic flow velocity of < 3 m/s, 3.0-3.9 m/s, and > 4 m/s) is
ACCEPTED MANUSCRIPT 6
thought to indicate mild, moderate, and severe AS, respectively. The shape of the maximum
T
aortic flow velocity profile gives a clue to the stenosis severity. In mild to moderate aortic
RI P
stenosis, the maximum flow velocity is commonly noted during the early phase of ejection time, whereas the maximum flow velocity in severe AS occurs at mid-ejection phase (Figure 3).
SC
However, it should be noted that an early peaking profile might be seen despite severe AS. If
NU
there is significant co-existent mitral regurgitation, the forward flow may decrease during the systolic phase if a sizable amount leaks into the left atrium, thereby distorting velocity since it is
MA
determined by flow rate. The ratio of proximal and distal velocity-time integral (VTI) is an index of AS severity, with an index of 0.25 pointing to severe AS. Using the maximum velocity profile
ED
of flow recorded distal to the valve, both maximum instantaneous and mean gradients are
PT
calculated using a modified Bernoulli equation, 4 × (V22-V11), or simply 4×V22, where V1 is the
CE
velocity proximal to the valve and V2 is the distal velocity 11. The Doppler method’s accuracy of calculating pressure gradients has been validated by simultaneous catheter-derived valve
AC
gradients. 12 Notice should be made to the differences in maximum instantaneous gradient as deduced from Doppler versus the peak-to-peak gradient deduced from the catheterization method. While mean gradients by Doppler and catheterization are similar, the maximum gradients are not. Doppler method yields the true maximum gradient, while the peak-to-peak gradient measured between LV and aortic pressure via catheterization is lower. Mean gradients of < 20 mm Hg, 20-39 m/s and >40 mm Hg are considered to indicate mild, moderate, and severe AS, respectively. Although the AHA/ACC/ASE guidelines state that severe AS is associated with flow velocity of > 4 m/s, peak gradient of > 65 mm Hg, and mean gradient of > 40 mm Hg, 9 it would be a folly to rely on velocities and gradients alone, unless the aortic flow
ACCEPTED MANUSCRIPT 7
velocity is more than 5 m/s in the setting of a normal stroke volume (SV). Efforts should be
T
made to obtain aortic valve area in patients with AS because a low forward SV due to a variety
RI P
of disorders could result in lower velocities and lower pressure gradients despite the presence
SC
of severe AS. Aortic Valve Area and AVA index
NU
The aortic valve area indexed to the body size is the best indicator of the severity of AS. The
MA
AVA can be derived from Doppler hemodynamic data (Effective or Functional AVA) or by planimetry (Anatomic AVA). In order to calculate the aortic valve area by Doppler
ED
hemodynamics, stroke volume must first be determined by multiplying the LV outflow area
PT
(from its diameter, use radius [r] to find area via πr2) by the VTI of proximal flow profile; then, employing the concept of the continuity equation, AVA is calculated by dividing the stroke
CE
volume by VTI of the maximum distal flow velocity profile (Figure 2). Potential technical errors
AC
that need to be avoided in the Doppler method include wrong measurements of LV outflow diameter and incorrect recordings of flow velocities. The assumption in computing the stroke volume in the LV outflow is that the outflow area is circular. This may not be valid if asymmetrical hypertrophy of the basal ventricular septum is present. 3D imaging could provide the correct area of the outflow directly and obviate the need to rely on the outflow diameter. Another potential pitfall is misjudging the maximum velocity profile. Interrogation of the flow profile in parasternal, apical, suprasternal, and subcostal acoustic windows is essential so as not to miss the maximum flow profile. An appraisal of the ratio of V1 to V2 velocity provides another index of severity, with a ratio of < 0.25 indicating severe AS and > 0.50 pointing to mild. Doppler
ACCEPTED MANUSCRIPT 8
recording measures the maximum pressure difference between the LA and the vena contracta
T
located immediately beyond the orifice. As the flow jet decelerates beyond, a fall in kinetic
RI P
energy results in recovery of some pressure and thus a rise in aortic static pressure. 13 Therefore, the effective afterload caused by the stenotic valve may be slightly lower than that
SC
depicted by the Doppler derived pressure gradient. Nevertheless, this overestimation does not
NU
provoke a major practical problem, except in the setting of a small aorta or a prosthetic valve. The anatomic AVA is obtained from the short-axis two- or three-dimensional images by tracing
MA
the orifice border when it is maximally open during systole. 6-8 Transesophageal imaging reliably
ED
depicts the valve area in more than 90% of patients with AS. In about 75% of all AS patients, AVA can be measured by planimetry on transthoracic images. Emphasis should be placed on
PT
ensuring that the measurement is at the valve tip level and not across the body of the valve,
CE
and on employing optimal ultrasound gain and dynamic range. In patients with moderate and severe AS, anatomic AVA is not influenced by changes in stroke volume and is therefore reliable
AC
even in the setting of a low stroke volume. While the determination of AVA is an essential component of the assessment of AS, with an AVA < 1 cm2 considered severe, it is more appropriate to calculate AVA indexed to body size, specifically body surface area. An AVA index (AVAi) of < 0.6 cm2/m2 is considered to be a marker of severe AS. Criteria for assessing the severity of AS in the current era are listed in Table 2. Exercise echocardiography yields additional information in asymptomatic AS patients 14. The patient’s effort tolerance, the change in valve gradient and the degree of myocardial response to increased demand are parameters that have prognostic and therapeutic implications. It is worth noting that the
ACCEPTED MANUSCRIPT 9
“conventional criteria” employed in the past to evaluate AS may not be valid in all patients,
RI P
Low Flow, Low Gradient, Severe AS with Low or Normal LV EF
T
particularly in those with a low flow state. This issue is discussed below.
SC
One concern of relying on the aortic valve area as a marker of AS severity is that the valve orifice area calculation could be erroneous in the setting of LV dysfunction and low stroke
NU
volume, as the valve may fail to open fully due to a low flow state. This impression came to be
MA
accepted from observations in the catheterization laboratory that used Gorlin equation to derive the AVA. 15,16 This should not be surprising since one of the essential components of
ED
Gorlin equation is that the mean gradient can be expected to decrease if the flow is low.
PT
Conversely, however, the anatomic orifice area of a thick, calcified valve does not change with alterations in flow. 17,18 This has been demonstrated by recording aortic valve area in patients
CE
with AS at various flow rates. Thus, in patients with low flow states, deriving anatomic AVA by
AC
transesophageal or transthoracic echocardiography is a reliable approach to assess the severity of AS. Dobutamine stress echocardiography is another option in a low flow scenario. With dobutamine, the stroke volume can be increased to a normal or acceptable level, and AVA recalculated during stress. 19,20 Another advantage of dobutamine stress testing is the opportunity to assess myocardial contractile reserve. Patients with contractile reserve have a better outlook with intervention than those without. 21
Despite severe AS, mean gradient could be low not only due to systolic LV dysfunction, but also
ACCEPTED MANUSCRIPT 10
due to other mechanisms (Figure 4). Severe diastolic LV dysfunction from varied causes can
T
impede LV filling and compromise forward stroke volume. Likewise, severe systolic and/or
RI P
diastolic RV dysfunction can lead to low stroke volume. Coexistent mitral stenosis can result in decreased LV filling; mitral regurgitation can steal the stroke volume away from the aorta; and
SC
tricuspid disorders can operate through similar mechanisms.
NU
It is also important to realize that, despite normal LV ejection fraction (EF), low gradient may be
MA
encountered in severe AS when the LV afterload is high or when the ventricle is anatomically small (referred to as, “paradoxical low flow AS”). 22-24, 24a Increased afterload offers resistance to
ED
LV ejection, while a small ventricle fills less and offers reduced forward SV; often these two exist together, and are frequently observed in elderly patients. Therefore, one should assess
PT
the total hemodynamic burden on the left ventricle. Energy loss index (ELI) is a parameter that
CE
expresses the LV workload. 25 It can be calculated by gauging the cross-sectional area of the
AC
aorta (Aa) from its diameter and using the equation: ELI = (AVA × Aa)/(Aa – AVA)/body surface area. Global (valvular + arterial) hemodynamic load to the LV should also be assessed in patients with AS. Valvulo-arterial impedance (Zva) provides such an index; it is calculated by dividing estimated LV systolic pressure (systolic arterial pressure + mean transvalvular gradient) by the indexed stroke volume.23 Zva over 5 is considered to be high. This index appears to have prognostic implications and thus should be integrated in the overall decision-making process.
Echocardiographic Guidance for Interventions
ACCEPTED MANUSCRIPT 11
The options for interventions in patients with AS include surgical aortic valve replacement
T
(SAVR) or transcutaneous aortic valve implantation 26,27. In patients undergoing SAVR,
RI P
intraoperative TEE is often employed to reassess aortic root and aortic valve anatomy, evaluate surgical efficacy, and recognize immediate, post-operative complications, such as paravalvular
SC
regurgitation (Figure 5). The measurements of the aortic ring and ascending aorta, as
NU
mentioned earlier, are important to deciding the type and size of the prosthesis for patients, in whom TAVI is considered. During the procedure, whether via a transfemoral or transapical
MA
approach, TEE is useful in displaying the position of the delivery catheters and placement of the valve. 28,29 Additionally, post-procedure complications, such as paravalvular regurgitation,
ED
myocardial perforation, and hemopericardium, are instantly recognized.
PT
The Syndrome of Degenerative Calcific Aortic Stenosis
CE
Elderly patients with AS often have other disorders beyond aortic valve narrowing. 30,31
AC
Hypertension and atherosclerosis are associated with increased afterload to the ventricle. LV diastolic and systolic function could be abnormal secondary to AS, as well as to concomitant hypertension, ischemic heart disease, or other disorders. Co-existent degenerative mitral valve disease of varying severity could be present. Pulmonary hypertension, right ventricular dysfunction, and tricuspid regurgitation could be present. These associated disorders could influence the degree of hemodynamic perturbances, symptom expression, and clinical outlook. Degenerative calcific AS in older patients should be considered as more of a syndrome rather than just a valve disease. Awareness of various facets of this syndrome should be considered in the clinical evaluation of a patient with AS. Two-dimensional and Doppler examination provides
ACCEPTED MANUSCRIPT 12
comprehensive information to assess both the severity of AS and all the non-valvular
T
derangements associated with valve stenosis.
RI P
Co-existent Valve Disease
SC
Aortic regurgitation (AR) could be associated with AS in some patients. While AS is predominantly a pressure overload disorder, AR adds volume overload to the left ventricle in
NU
addition to pressure overload. If moderate or more severe AR is present, the aortic valve
MA
velocities and gradients increase because of increased forward SV. The anatomic AVA should still be reliable under this circumstance. The decision of when to intervene in a patient with
ED
such mixed valve disease should be made on the overall clinical picture that incudes symptoms,
PT
LV size and function, and other co-existent issues. Elderly patients with degenerative, calcific AS frequently have degenerative mitral valve disease as well, either in the form of mitral stenosis
CE
or regurgitation. The morphologic and functional severity of the mitral valve disease should be
AC
assessed to understand its contribution to the pathophysiology and symptoms. If there is significant mitral valve disease, the patient may not derive benefits from aortic valve intervention alone.
The Left Ventricle and Other Disorders The volumes and ejection fraction of the LV should be quantified since they have prognostic and therapeutic implications. Valve intervention is recommended if LV EF is less than 50%. Recent work employing speckle tracking echocardiography and cardiac magnetic resonance suggests that those with severe AS may have abnormal left ventricle even when the EF is
ACCEPTED MANUSCRIPT 13
normal.32,33 LV longitudinal strain of less than -15 appears to connote an adverse outcome with
T
normal longitudinal strain resting around -20. This measurement is expected to become a
RI P
standard approach to identifying early LV dysfunction and may influence therapeutic decision making in the future. Echocardiographic parameters of diastolic dysfunction, measures of
SC
pulmonary artery pressures,34 and RV function are important in the overall assessment of a
NU
patient with AS.
MA
Management Implications of Echocardiographic Findings of Aortic Stenosis Patients with AS of mild and moderate severity should be followed medically with periodic
ED
clinical and echocardiographic examinations. Echocardiographic evaluation annually or every 6
PT
months is prudent when AS is moderate since the stenosis severity can rapidly progress in some patients. Gauging the calcium burden and velocity increase is useful in identifying such patients.
CE
In patients with severe AS but with no symptoms, exercise echocardiography allows for an
AC
objective assessment of the effort tolerance and hemodynamic response to exercise. Left ventricular contractile reserve assessed by dobutamine stress echocardiography has prognostic implications in patients with severe AS and a low gradient. In older patients with co-existent disorders, echocardiographic and clinical evaluation provides a detailed portrait of the patient’s illness and guides therapeutic decision-making on the type of treatment.
ACCEPTED MANUSCRIPT 14
References:
T
1. Smith N, McAnulty JH, Rahimtoola SH: Severe aortic stenosis with impaired left
RI P
ventricular function and clinical heart failure: results of valve replacement. Circulation
SC
58:225, 1978
2. Pellikka PA, Sarano ME, Nishimura RA, et al: Outcome of 622 adults with asymptomatic,
NU
hemodynamically significant aortic stenosis during prolonged follow up. Circulation
MA
111:3290-5, 2005
3. Weyman AE: Cross-sectional echocardiography. Philadelphia, PA, Lea & Febiger,1982
ED
4. Oh JK, Deward JB, Tajik AJ: The Echo manual (ed 2). Philadelphia, PA, Lippincott, 2006
Springer, NY, 2010
PT
5. Faletra FF, De Castro S, Pandian NG, et al: Atlas of transesophgeal echocardiography.
CE
6. Stoddard MF, Arce J, Liddell NE, et al: Two-dimensional trans-esophageal echocardiographic determination of aortic valve area in adults with aortic stenosis. Am
AC
Heart J 122:1415, 1991
7. Hoffmann R, Flachskampf FA, Hanrath P: Planimetry of orifice area in aortic stenosis using multiplane trans-esophageal echocardiography. J Am CollCardiol 22:259, 1993. 8. Arsenault M, Masani N, Magni G, et al: Variation of anatomic aortic valve area during ejection in patients with valvular aortic stenosis evaluated by two-dimensional echocardiographic plannimetry. Am J Cardiol 32:1931, 1998
ACCEPTED MANUSCRIPT 15
9. Nishimura RA, Otto CM, Bonow RO, et al: 2014 AHA/ACC Guideline for the management
T
of patients with valvular heart disease: a report of the ACC/AHA Task Force on Practice
RI P
Guidelines. J Am Coll Cardiol, doi: 10.1016/j.jacc.2014.02.536
heart disease. Eur Heart J 28:230-68, 2007
SC
10. Vahanian A, Baumgartner H, Bax J, et al: Guidelines on the management of valvular
NU
10a. Baumgartner H, Hung J, Bermejo J, et al. Echocardipgraphic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 22:1-23,
MA
2009
11. Hatle L, Angelson A, Tromsdal A: Non-invasive assessment of aortic stenosis by Doppler
ED
ultrasound. Br Heart J 43:284-292, 1980
PT
12. Currie PJ, Seward JB, Reeder GS, et al: Continuous wave Doppler echocardiographic
CE
assessment of severity of calcific aortic stenosis: A simultaneous Doppler-catheter correlative study in 100 adult patients. Circulation 71:1162-1169, 1985
AC
13. Laskey WK, Kussmal WG: Pressure recovery in aortic valve stenosis. Circulation 89:116121, 1994
14. Lancellotti P, Lebois F, Simon M, Tombeux C, Chauvel C, Pierard L: Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 112:1377-82, 2005 15. Gorlin R, Gorlin SG: Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves and central circulatory shunts. Am Heart J 41:1, 1951
ACCEPTED MANUSCRIPT 16
16. Carabello BA, Grossman W: Calculation of stenotic valve orifice area, in Grossman W
T
(eds), Lea and Febiger: Cardiac catheterization and angiography (ed 3), Philadelphia,PA,
RI P
1986, pp.143
17. Tardif JC, Miller DS, PandianNG,et al: Effects of variaitons in flow on aortic valve area in
SC
aortic stenosis based on in-vivo planimetry of aortic valve area by
NU
multiplanetransesophageal echocardiography. Am J Cardiol 76:193-8, 1995 18. Tardiff JC, Rodrigues G, Hardy JF, et al: Simultaneous determination of aortic valve area
MA
by the gorlin formula and by trans-esophageal echocardiography under different transvalvular flow conditions: Evidence that anatomic aortic valve area does not change
ED
with variations in flow in aortic stenosis. J Am CollCardiol 29:1296, 1997
PT
19. eFilippi CR, Willett DL, Brickner ME, et al: Usefulness of doubtamine echocardiography
CE
indistinguishing severe from non-severe valvular aortic stenosis in patients with depressed left ventricular function and low trans-valvular gradients. Am J Cardiol
AC
75:191-4, 1995
20. Nishimura RA, Grantham JA, Connolly HM, et al: Low-output, low-gradient aortic stenosis in patients with depressed left ventricular systolic function: the clinical utility of dobutamine challenge in the catheterization laboratory. Circulation 106:809, 2002 21. Monin JL, Quere JP, Monchi M, et al: Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 108:319-24, 2003
ACCEPTED MANUSCRIPT 17
22. Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P: Paradoxical low-flow, low-gradient severe
T
aortic stenosis despite preserved ejection fraction is associated with higher afterload
RI P
and reduced survival. Circulation 115:2856, 2007
23. Dumesnil JG, Pibarot P, Carabello B: Paradoxical low flow and/or low gradient severe
SC
aortic stenosis despite preserved left ventricular ejection fraction: implications for
NU
diagnosis and treatment. Eur Heart J 31:281-9, 2010
24. Jander N, Minners J, Holme I, et al: Outcome of patients with low-gradient “severe”
MA
aortic stenosis and preserved ejection fraction. Circulation 123:887, 2011 24a. Eleid MF, Sorajja P, Michelena HI, et al: Flow-gradient patterns in severe aortic
ED
stenosis with preserved ejection fraction: Clinical characteristics and predictors of
PT
survival. Circulation 128:1781-1789, 2013
CE
25. Garcia D, Pibarot P, Dumesnil JG, et al: Assessment of aortic valve stenosis severity: A
2000
AC
new index based on the energy loss concept (in process citation). Circulation 101:765,
26. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al: Per-cutaneous trans-catheter implantation of an aortic valve prosthesis for calcificaortic stenosis: First human case description. Circulation 106:3006-8, 2002 27. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svennsson LG, et al: Trans-catheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597-607, 2010 28. Faletra FF, Perk G, Pandian NG, et al: Real-time 3D Interventionalechocardiography. Springer, NY, 2013
ACCEPTED MANUSCRIPT 18
29. Bloomfield GS, Gillam LD, Hahn RT, Kapadia S, Leipsic J, Lerakis S, Tuzcu M, Douglas PS: A
T
Practical guide to multimodality imaging of transcatheter aortic valve replacement. JACC
RI P
Cardiovasc Imaging 5(4):441-55, 2012
30. Mallavarapu RK, Mankad S, Nanda NC. Echocardiographic assessment of aortic stenosis
SC
in the elderly. Am J GeriatrCardiol 16:343-8, 2007
NU
31. Ramamurthi A, Pandian NG, Gangadharamurthy D, et al: The syndrome of degenerative calcific aortic stenosis: Prevalence of multiple pathophysiologic disorders in association
MA
with valvular stenosis and their implications. Echocardiography 30:1-7, 2013 32. Lancellotti P, Donal E, Magne J, et al. Impact of global left ventricular afterload on left
ED
ventricular function in asymptomatic severe aortic stenosis: a two-dimensional speckle
PT
tracking study. Eur J Echocardiogr 11:537-43, 2010
CE
33. Weidemann F, Herrmann S, Stork S, et al: Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 120:577-84, 2009
AC
34. Malouf JF, Enriquez-Sarano M, Pellikka PA, et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol 40: 789-795, 2002
ACCEPTED MANUSCRIPT 19
Figure Legends:
RI P
T
Figure 1. Two- and three-dimensional images of the aortic valve. A) Normal aortic valve; B) Moderate
SC
aortic stenosis (AS) with decreased valve area; C) Severe AS with markedly decreased valve area; D) A bicuspid aortic valve with mild AS; E) Three-dimensional image of the same valve; F)
NU
Three-dimensional image of a severely stenotic valve.
MA
Figure 2.
ED
The method of deriving aortic valve area by continuity equation. Left: LA outflow diameter measurement to derive LV outflow area (A1); Middle: Pulsed Doppler recording of LV outflow
PT
flow velocity profile to obtain the velocity time integral (VTI1) to calculate the stroke volume;
AC
Figure 3.
CE
Right: Distal maximal flow velocity recording by continuous wave Doppler to derive VTI 2.
Hemodynamics in aortic stenosis. Top panel: Maximum velocity profiles of mild AS with a velocity of 2 m/s (left), moderate AS with a velocity of 3.2 m/s (middle), and severe AS with a velocity of 4.4 m/s (right). Bottom left: Schematic left ventricular and aortic pressure waveforms of normal (left) and in an example of severe AS. On the right are Doppler recording of a patient with severe AS. Maximum instantaneous gradient is derived by using the formula 4xV2 and mean gradient from the mean of multiple instantaneous gradients from the profile. Mean gradients by Doppler and pressure recordings are similar but the peak to peak gradient obtained from the invasive pressure recordings is lower than that obtained by Doppler.
ACCEPTED MANUSCRIPT 20
Figure 4.
T
Schematic portraying multiple mechanisms that can result in a low gradient across the aortic
RI P
valve despite severe AS.
SC
Figure 5.
NU
Transesophageal echocardiographic images during transcutaneous aortic valve implantation.
MA
A) Image showing a stenotic aortic valve with a guide-wire across. LA=left atrium; LV=left ventricle; Ao=aorta. B) Catheter with the prosthesis across the valve (arrow). C) 3-dimensional
ED
image during inflation of the prosthesis (arrow). D) A short-axis view of the prosthesis after implantation. E) Significant paravalvular regurgitation noted (arrow). F) 3-dimensional image
AC
CE
PT
showing paravalvular regurgitation.
ACCEPTED MANUSCRIPT 21
AC
CE
PT
ED
MA
NU
SC
RI P
T
Fig 1
ACCEPTED MANUSCRIPT 22
AC
CE
PT
ED
MA
NU
SC
RI P
T
Fig 2
ACCEPTED MANUSCRIPT 23
AC
CE
PT
ED
MA
NU
SC
RI P
T
Fig 3
ACCEPTED MANUSCRIPT 24
AC
CE
PT
ED
MA
NU
SC
RI P
T
Fig 4
ACCEPTED MANUSCRIPT 25
AC
CE
PT
ED
MA
NU
SC
RI P
T
Fig 5
ACCEPTED MANUSCRIPT 26
T
Table 1. Comprehensive Echocardiographic Evaluation of Aortic Stenosis
RI P
Aortic valve anatomy
SC
Number of cusps, calcium burden, aortic valve area by planimetry
NU
Hemodynamic Measurements
MA
LV outflow velocity time integral proximal to the valve
ED
Flow velocity and velocity time integral (VTI) across the aortic valve
PT
Proximal to distal VTI ratio
CE
Maximum instantaneous gradient and mean gradient
AC
Aortic valve area by continuity equation
Energy Loss Index
Valvulo-arterial impedance (global hemodynamic load, Zva)
Other Data
Aortic ring, sinus of Valsalva, Sino-tubular junction, and ascending aorta diameters
LV volume and ejection fraction, LV longitudinal strain
ACCEPTED MANUSCRIPT 27
T
Measures of diastolic dysfunction
RI P
Pulmonary artery systolic pressure
SC
Right ventricular size and function
AC
CE
PT
ED
MA
NU
Coronary artery disease and other co-existing disorders
ACCEPTED MANUSCRIPT 28
Table 2. Suggested Criteria for Grading the Severity of Aortic Stenosis
T
_____________________________________________________________________________________ Moderate AS
Mild thickening of the valve
Mild-moderate valve thickening/calcification
Mild restriction to opening
Moderate restriction to opening
Aortic Vmax 2 m/s or less
Aortic Vmax 3-3.9 m/s
Mean Pressure Gradient < 20 mm Hg
Mean Pressure Gradient 20-39 mm Hg
NU
SC
RI P
Mild AS
Aortic Valve Area > 1.5 cm2
Aortic Valve Area < 1 cm2 ; AVAi 0.7-1.0 m2/m2
Severe AS with Normal Flow
Marked restriction to opening
PT
SVi >35 mL/m2
ED
Severe thickening/calcification of the valve
CE
Aortic >Vmax 4 m/s
MA
_____________________________________________________________________________________ Severe AS with Low Flow Severe thickening/calcification of the valve Marked restriction to opening SVi <35 mL/m2 Aortic Vmax 3 - 4 m/s Mean Pressure Gradient 20-40 mm Hg
Aortic Valve Area < 1 cm2; AVAi < 0.6 m2/m2
Aortic Valve Area < 1 cm2 ; AVAi < 0.6 m2/m2
AC
Mean Pressure Gradient >40 mm Hg
(Abbreviations as in text)